AAAS Reviews 'Unusual' Funding Year for R&D | GenomeWeb

WASHINGTON, DC (GenomeWeb News) – Sandwiched between President Barack Obama's speech on Monday at the National Academies of Science, in which he called for an "historic investment" in basic science, and the expected arrival of the White House's budget proposal for 2010, the American Association for the Advancement of Science met Thursday to discuss the past year's funding surprises and the climate of R&D spending in an uncertain economy.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.